Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-177400 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 24, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
900
Total Value
$38,717.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Apr 22, 2026 | Exercise/Conversion | 100 | $30.17 | $3,017.00 | 61,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 22, 2026 | Exercise/Conversion | 200 | $43.50 | $8,700.00 | 61,502 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Apr 22, 2026 | Sale | 300 | $90.00 | $27,000.00 | 61,202 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 22, 2026 | Exercise/Conversion | 100 | $0.00 | $0.00 | 45,434 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Apr 22, 2026 | Exercise/Conversion | 200 | $0.00 | $0.00 | 58,263 | Direct | โ | View Details |